Sort   by:  
 Page size 
Randomized controlled trial of TUDCA supplementation in people with progressive multiple sclerosis
SEPN1-related myopathy depends on the oxidoreductase ERO1 alpha and is druggable with the chemical chaperone TUDCA
ORGANISM(S): Homo sapiens (Human) 
2024-05-24 | PXD047157 | Pride
We examined the effect of oral TUDCA treatment on hepatic steatosis and associated changes in hepatic gene expression in ob/ob mice. We administered TUDCA to ob/ob mice at a dose of 500 mg/kg twice a day by gastric gavage for 3 weeks. Body weight, glucose homeostasis, endoplasmic reticulum (ER) stre...
ORGANISM(S): Mus musculus 
Transcriptome profile of S. cerevisiae treated with tauroursodeoxycholic acid (TUDCA)
Our work demonstrated an impairment in cognitive, social and emotional behavior in aged sacs knockout zebrafish similar to that observed in human patients. Transcriptomic and proteomic data from the adult brains revealing alterations in several genes related to circadian rhythms and neuroinflammatio...
ORGANISM(S): Danio rerio (Zebrafish) (Brachydanio rerio) 
2025-09-03 | PXD058522 | Pride
Tauroursodeoxycholic Acid (TUDCA) Reduces ER Stress and Lessens Disease Activity in Ulcerative Colitis
Cells respond to endoplasmic reticulum (ER) stress through activation of signaling pathways such as the Unfolded Protein Response (UPR) which improve the ER folding environment capacity upon changes in misfolded protein burden. Small molecules termed chemical chaperones can attenuate the UPR under s...
ORGANISM(S): Saccharomyces cerevisiae 
2024-11-13 | GSE186390 | GEO
Sort   by:  
 Page size